242 related articles for article (PubMed ID: 33609603)
1. Melancholic features in major depression - a European multicenter study.
Dold M; Bartova L; Fugger G; Kautzky A; Mitschek MMM; Fabbri C; Montgomery S; Zohar J; Souery D; Mendlewicz J; Serretti A; Kasper S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110285. PubMed ID: 33609603
[TBL] [Abstract][Full Text] [Related]
2. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study.
Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S
Eur Neuropsychopharmacol; 2020 Dec; 41():70-80. PubMed ID: 33046351
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
Bobo WV; Chen H; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Lesser IM; Kornstein SG; Wisniewski SR; Rush AJ; Shelton RC
J Affect Disord; 2011 Oct; 133(3):467-76. PubMed ID: 21601287
[TBL] [Abstract][Full Text] [Related]
4. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries.
Fugger G; Bartova L; Fabbri C; Fanelli G; Dold M; Swoboda MMM; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):715-727. PubMed ID: 34989830
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study.
Dold M; Bartova L; Fugger G; Mitschek MM; Fabbri C; Serretti A; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S
J Affect Disord; 2022 Jan; 296():485-492. PubMed ID: 34653701
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study.
Dold M; Kautzky A; Bartova L; Rabl U; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1960-1971. PubMed ID: 27816317
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.
Dold M; Bartova L; Kautzky A; Serretti A; Porcelli S; Souery D; Mendlewicz J; Montgomery S; Zohar J; Kasper S
Eur Neuropsychopharmacol; 2018 Dec; 28(12):1305-1313. PubMed ID: 30446357
[TBL] [Abstract][Full Text] [Related]
8. Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.
Dold M; Bartova L; Kautzky A; Porcelli S; Montgomery S; Zohar J; Mendlewicz J; Souery D; Serretti A; Kasper S
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677267
[TBL] [Abstract][Full Text] [Related]
9. Demographic and clinical features and prescribing patterns of psychotropic medications in patients with the melancholic subtype of major depressive disorder in China.
Xiang YT; Wang G; Hu C; Guo T; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Zheng QW; Chen DF; Fang YR; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
PLoS One; 2012; 7(6):e39840. PubMed ID: 22768140
[TBL] [Abstract][Full Text] [Related]
10. Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.
Dold M; Bartova L; Mendlewicz J; Souery D; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
Acta Psychiatr Scand; 2018 May; 137(5):401-412. PubMed ID: 29492960
[TBL] [Abstract][Full Text] [Related]
11. Melancholic features and treatment outcome to selective serotonin reuptake inhibitors in major depressive disorder: A re-analysis of the STAR*D trial.
Szmulewicz A; Valerio MP; Lomastro J; Martino DJ
J Affect Disord; 2024 Feb; 347():101-107. PubMed ID: 37981037
[TBL] [Abstract][Full Text] [Related]
12. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.
Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2017 Jul; 27(7):625-632. PubMed ID: 28579072
[TBL] [Abstract][Full Text] [Related]
13. A quantitative review on outcome-to-antidepressants in melancholic unipolar depression.
Valerio MP; Szmulewicz AG; Martino DJ
Psychiatry Res; 2018 Jul; 265():100-110. PubMed ID: 29702301
[TBL] [Abstract][Full Text] [Related]
14. Response to antidepressants in major depressive disorder with melancholic features: the CRESCEND study.
Yang SJ; Stewart R; Kang HJ; Kim SY; Bae KY; Kim JM; Jung SW; Lee MS; Yim HW; Jun TY
J Affect Disord; 2013 Jan; 144(1-2):42-50. PubMed ID: 22840632
[TBL] [Abstract][Full Text] [Related]
15. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
16. Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study.
Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
Eur Neuropsychopharmacol; 2019 Jun; 29(6):777-785. PubMed ID: 31006562
[TBL] [Abstract][Full Text] [Related]
17. Influence of painful physical symptoms in the treatment of Japanese patients with melancholic major depressive disorder: A prospective cohort study.
Sekine A; Hozumi S; Shimizu T
Psychiatry Res; 2016 Aug; 242():240-244. PubMed ID: 27294798
[TBL] [Abstract][Full Text] [Related]
18. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
Hirschfeld RM
J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
[TBL] [Abstract][Full Text] [Related]
20. Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.
Dold M; Bartova L; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
J Affect Disord; 2018 Feb; 227():254-259. PubMed ID: 29107818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
